1q21.1 deletion and a rare functional polymorphism in siblings with thrombocytopenia-absent radius-like phenotypes

Seth A Brodie, Jean Paul Rodriguez-Aulet, Neelam Giri, Jieqiong Dai, Mia Steinberg, Joshua J Waterfall, David Roberson, Bari J Ballew, Weiyin Zhou, Sarah L Anzick, Yuan Jiang, Yonghong Wang, Yuelin J Zhu, Paul S Meltzer, Joseph Boland, Blanche P Alter, Sharon A Savage, Seth A Brodie, Jean Paul Rodriguez-Aulet, Neelam Giri, Jieqiong Dai, Mia Steinberg, Joshua J Waterfall, David Roberson, Bari J Ballew, Weiyin Zhou, Sarah L Anzick, Yuan Jiang, Yonghong Wang, Yuelin J Zhu, Paul S Meltzer, Joseph Boland, Blanche P Alter, Sharon A Savage

Abstract

Thrombocytopenia-absent radii (TAR) syndrome, characterized by neonatal thrombocytopenia and bilateral radial aplasia with thumbs present, is typically caused by the inheritance of a 1q21.1 deletion and a single-nucelotide polymorphism in RBM8A on the nondeleted allele. We evaluated two siblings with TAR-like dysmorphology but lacking thrombocytopenia in infancy. Family NCI-107 participated in an IRB-approved cohort study and underwent comprehensive clinical and genomic evaluations, including aCGH, whole-exome, whole-genome, and targeted sequencing. Gene expression assays and electromobility shift assays (EMSAs) were performed to evaluate the variant of interest. The previously identified TAR-associated 1q21.1 deletion was present in the affected siblings and one healthy parent. Multiple sequencing approaches did not identify previously described TAR-associated SNPs or mutations in relevant genes. We discovered rs61746197 A > G heterozygosity in the parent without the deletion and apparent hemizygosity in both siblings. rs61746197 A > G overlaps a RelA-p65 binding motif, and EMSAs indicate the A allele has higher transcription factor binding efficiency than the G allele. Stimulation of K562 cells to induce megakaryocyte differentiation abrogated the shift of both reference and alternative probes. The 1q21.1 TAR-associated deletion in combination with the G variant of rs61746197 on the nondeleted allele is associated with a TAR-like phenotype. rs61746197 G could be a functional enhancer/repressor element, but more studies are required to identify the specific factor(s) responsible. Overall, our findings suggest a role of rs61746197 A > G and human disease in the setting of a 1q21.1 deletion on the other chromosome.

Trial registration: ClinicalTrials.gov NCT00027274.

Keywords: congenital thrombocytopenia; deformed radius.

Published by Cold Spring Harbor Laboratory Press.

Figures

Figure 1.
Figure 1.
Skeletal features of study participants. (AC) Proband, NCI-107-1. (A) Absent left radius and hypoplastic left ulna; (B) absent right radius and short right ulna; status post–multiple corrective surgeries for right thumb hypoplasia including tendon transfer and centralization; (C) normal right humerus. (D,E) Sister, NCI-107-2. (D) Wide left radius with mild hypoplasia and bony fusion of the proximal radial head to the distal humerus at the left elbow; (E) the right radius and ulna are normal; (D,E) both hands are normal with complete skeletal maturation.
Figure 2.
Figure 2.
Schematic of 1q21.1 locus. The deleted region in family NCI-107 is shown in relation to the deletion previously reported in thrombocytopenia-absent radius (TAR) syndrome based on the hg38 reference genome. The transcription factor binding site (TFBS) affected by rs61746197 A > G is denoted as are the locations of the previously TAR-associated SNPs, rs139428292 and rs201779890.
Figure 3.
Figure 3.
Electromobility shift assays (EMSAs) suggest that rs61746197 A > G is a functional SNP. (A) Ten micrograms of unstimulated nuclear extract from K562 cells was incubated with reference (Ref, R) or alternative (Alt, A) probe as indicated. Cold Ref probe titrates signal away from Alt at a lower stoichiometric ratio than the converse (arrow and compare lanes 1113 with 68). (B) Unstimulated extract (left panel, U) exhibits a markedly stronger baseline shift than TPA stimulated extract (right panel, S). Unstimulated nuclear extract (U) when incubated with labeled alternative probe (A) produces a novel secondary shift not observed with either the reference probe (R) or the TPA stimulated extract (S). Addition of RelA–p65 antibody abrogates this secondary shift (arrow).

References

    1. Ahmad R, Pope S. 2008. Association of Mayer–Rokitansky–Küster–Hauser syndrome with thrombocytopenia absent radii syndrome: a rare presentation. Eur J Obstet Gynecol Reprod Biol 139: 257–258. 10.1016/j.ejogrb.2007.01.018
    1. Albers CA, Paul DS, Schulze H, Freson K, Stephens JC, Smethurst PA, Jolley JD, Cvejic A, Kostadima M, Bertone P, et al. 2012. Compound inheritance of a low-frequency regulatory SNP and a rare null mutation in exon-junction complex subunit RBM8A causes TAR syndrome. Nat Genet 44: 435–439. S431-432 10.1038/ng.1083
    1. Alter BP, Giri N, Savage SA, Rosenberg PS. 2018. Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up. Haematologica 103: 30–39. 10.3324/haematol.2017.178111
    1. Ballew BJ, Yeager M, Jacobs K, Giri N, Boland J, Burdett L, Alter BP, Savage SA. 2013. Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita. Hum Genet 132: 473–480. 10.1007/s00439-013-1265-8
    1. Greenhalgh KL, Howell RT, Bottani A, Ancliff PJ, Brunner HG, Verschuuren-Bemelmans CC, Vernon E, Brown KW, Newbury-Ecob RA. 2002. Thrombocytopenia-absent radius syndrome: a clinical genetic study. J Med Genet 39: 876–881. 10.1136/jmg.39.12.876
    1. GTEx Consortium. 2013. The Genotype-Tissue Expression (GTEx) project. Nat Genet 45: 580–585. 10.1038/ng.2653
    1. Hall JG, Levin J, Kuhn JP, Ottenheimer EJ, van Berkum KA, McKusick VA. 1969. Thrombocytopenia with absent radius (TAR). Medicine (Baltimore) 48: 411–439. 10.1097/00005792-196948060-00001
    1. Hansen SK, Baeuerle PA, Blasi F. 1994. Purification, reconstitution, and I κ B association of the c-Rel-p65 (RelA) complex, a strong activator of transcription. Mol Cell Biol 14: 2593–2603. 10.1128/MCB.14.4.2593
    1. Houeijeh A, Andrieux J, Saugier-Veber P, David A, Goldenberg A, Bonneau D, Fouassier M, Journel H, Martinovic J, Escande F, et al. 2011. Thrombocytopenia-absent radius (TAR) syndrome: a clinical genetic series of 14 further cases. impact of the associated 1q21.1 deletion on the genetic counselling. Eur J Med Genet 54: e471–e477. 10.1016/j.ejmg.2011.05.001
    1. Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alfoldi J, Wang Q, Collins RL, Laricchia KM, Ganna A, Birnbaum DP, et al. 2019. Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes. bioRxiv 10.1101/531210
    1. Klopocki E, Schulze H, Strauß G, Ott CE, Hall J, Trotier F, Fleischhauer S, Greenhalgh L, Newbury-Ecob RA, Neumann LM, et al. 2007. Complex inheritance pattern resembling autosomal recessive inheritance involving a microdeletion in thrombocytopenia-absent radius syndrome. Am J Hum Genet 80: 232–240. 10.1086/510919
    1. Landrum MJ, Kattman BL. 2018. ClinVar at five years: delivering on the promise. Hum Mutat 39: 1623–1630. 10.1002/humu.23641
    1. Manukjan G, Bösing H, Schmugge M, Strauss G, Schulze H. 2017. Impact of genetic variants on haematopoiesis in patients with thrombocytopenia absent radii (TAR) syndrome. Br J Haematol 179: 606–617. 10.1111/bjh.14913
    1. Matys V, Kel-Margoulis OV, Fricke E, Liebich I, Land S, Barre-Dirrie A, Reuter I, Chekmenev D, Krull M, Hornischer K, et al. 2006. TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res 34: D108–D110. 10.1093/nar/gkj143
    1. McDermott DA, Fong JC, Basson CT. 1993. Holt–Oram syndrome. In GeneReviews® (ed. Adam MP, Ardinger HH, Pagon RA, et al.). University of Washington, Seattle.
    1. Niihori T, Ouchi-Uchiyama M, Sasahara Y, Kaneko T, Hashii Y, Irie M, Sato A, Saito-Nanjo Y, Funayama R, Nagashima T, et al. 2015. Mutations in MECOM, encoding oncoprotein EVI1, cause radioulnar synostosis with amegakaryocytic thrombocytopenia. Am J Hum Genet 97: 848–854. 10.1016/j.ajhg.2015.10.010
    1. O'Bleness M, Searles VB, Dickens CM, Astling D, Albracht D, Mak AC, Lai YY, Lin C, Chu C, Graves T, et al. 2014. Finished sequence and assembly of the DUF1220-rich 1q21 region using a haploid human genome. BMC Genomics 15: 387 10.1186/1471-2164-15-387
    1. Rosenfeld JA, Traylor RN, Schaefer GB, McPherson EW, Ballif BC, Klopocki E, Mundlos S, Shaffer LG, Aylsworth AS, q21.1 Study Group. 2012. Proximal microdeletions and microduplications of 1q21.1 contribute to variable abnormal phenotypes. Eur J Hum Genet 20: 754–761. 10.1038/ejhg.2012.6
    1. Savage SA, Walsh MF. 2018. Myelodysplastic syndrome, acute myeloid leukemia, and cancer surveillance in fanconi anemia. Hematol Oncol Clin North Am 32: 657–668. 10.1016/j.hoc.2018.04.002
    1. Stein SJ, Baldwin AS. 2013. Deletion of the NF-κB subunit p65/RelA in the hematopoietic compartment leads to defects in hematopoietic stem cell function. Blood 121: 5015–5024. 10.1182/blood-2013-02-486142
    1. Thompson AA, Nguyen LT. 2000. Amegakaryocytic thrombocytopenia and radio-ulnar synostosis are associated with HOXA11 mutation. Nat Genet 26: 397–398. 10.1038/82511
    1. Toriello HV. 1993. Thrombocytopenia absent radius syndrome. In GeneReviews® (ed. Adam MP, Ardinger HH, Pagon RA, et al.). University of Washington, Seattle.
    1. Whitfield MF, Barr DG. 1976. Cows’ milk allergy in the syndrome of thrombocytopenia with absent radius. Arch Dis Child 51: 337–343. 10.1136/adc.51.5.337
    1. Wu S, Flint JK, Rezvani G, De Luca F. 2007. Nuclear factor-κB p65 facilitates longitudinal bone growth by inducing growth plate chondrocyte proliferation and differentiation and by preventing apoptosis. J Biol Chem 282: 33698–33706. 10.1074/jbc.M702991200

Source: PubMed

3
Abonnere